Navigation Links
New human trial shows stem cells are effective for failing hearts
Date:3/31/2014

WASHINGTON (March 31, 2014) Patients with severe ischemic heart disease and heart failure can benefit from a new treatment in which stem cells found in bone marrow are injected directly into the heart muscle, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.

"Our results show that this stem cell treatment is safe and it improves heart function when compared to placebo," said Anders Bruun Mathiasen, M.D., research fellow in the Cardiac Catherization Lab at Rigshospitalet University Hospital Copenhagen, and lead investigator of the study. "This represents an exciting development that has the potential to benefit many people who suffer from this common and deadly disease."

Ischemic heart disease, also known as coronary artery disease, is the number one cause of death for both men and women in the United States. It results from a gradual buildup of plaque in the heart's coronary arteries and can lead to chest pain, heart attack and heart failure.

The study is the largest placebo-controlled double-blind randomized trial to treat patients with chronic ischemic heart failure by injecting a type of stem cell known as mesenchymal stromal cells directly into the heart muscle.

Six months after treatment, patients who received stem cell injections had improved heart pump function compared to patients receiving a placebo. Treated patients showed an 8.2-milliliter decrease in the study's primary endpoint, end systolic volume, which indicates the lowest volume of blood in the heart during the pumping cycle and is a key measure of the heart's ability to pump effectively. The placebo group showed an increase of 6 milliliters in end systolic volume.

The study included 59 patients with chronic ischemic heart disease and severe heart failure. Each patient first underwent a procedure to extract a small amount of bone marrow. Researchers then isolated from the marrow a small number
'/>"/>

Contact: Beth Casteel
bcasteel@acc.org
202-375-6275
American College of Cardiology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Zebrafish discovery may shed light on human kidney function
2. Infected Tasmanian devils reveal how cancer cells evolve in response to humans
3. NIH-funded researchers use antibody treatment to protect humanized mice from HIV
4. First observation of a human HAT, key proteins in numerous pathologies
5. Toxin from brain cells triggers neuron loss in human ALS model
6. Screening for transformed human mesenchymal stromal cells with tumorigenic potential
7. Converting adult human cells to hair-follicle-generating stem cells
8. Successful regeneration of human skeletal muscle in mice
9. A scientific first: Physicists, physicians, engineers photograph radiation beams in the human body through the Cherenkov effect
10. Maricopa Community Colleges Consider Five Candidates for Top Human Resources Job
11. Loma Linda University Health Remembers Sir Run Run Shaw as a Philanthropist and Humanitarian in the World of Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Catalent Pharma Solutions, the ... development solutions for drugs, biologics and consumer health ... Clinical Supply Services, and Chris Greco, Manager, Comparator ... Strategies for Active Control Clinical Trials” at the ... place on the 9th – 10th September, 2014 ...
(Date:8/28/2014)... nasal septum cells. Researchers at the University and the ... the nasal septum are able to adapt to the ... articular cartilage defects. The nasal cartilage cells, ability to ... with the expression of so-called HOX genes. The scientific ... research results together with the report of the first ...
(Date:8/28/2014)... and over who identify themselves as ,old, feel worse ... they have lower value than younger age groups. , ... titled ,Being old and ill, across different countries: social ... data from the European Social Survey. Respondents, who were ... their health., The researchers found that those living in ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 BCC Research ... SURGICAL NAVIGATION SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the ... $419.7 million in 2013. Driven by the need for ... medical tourism in emerging geographies, the market is expected ... growth rate (CAGR) of 8.5% from 2013 through 2018. ...
(Date:8/28/2014)... 2014 AmeriPride Services, a leading textile ... the launch of its new Customer Portal, an online ... and more convenient for customers. The industry-leading digital tool ... communicate with the company. , Features of the new ... Access, download and pay bills online , ...
Breaking Medicine News(10 mins):Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... on Monday, August 11, 2008 at 8:30am ... ... Biopharmaceuticals,Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on the,acquisition, development ... including renal disease and cancer, today announced its results,for the second quarter ...
... Aug. 8 "The passage of federal,legislation two years ... by Congress to the alarming surge in childhood obesity ... for the school wellness movement,",says a 60-page report issued ... "That legislation has gotten the ball rolling by,identifying schools ...
... Inc., administrator for the,HealthShares(TM) Indexes, a series ... Traded Funds, today announced the following changes,effective ... August 11, 2008: Enzo Biochem,Inc. will replace ... the,HealthShares(TM) Infectious Disease Index and the HealthShares(TM),Composite ...
... mothers milk makes for even-keeled kids, , , FRIDAY, Aug. ... benefits to both mother and baby, including a stronger ... for mom. There are even some known psychological benefits ... But British researchers have recently discovered another mental bonus ...
... MedQuist,Inc.,(Nasdaq: MEDQ ) the largest Medical Transcription ... for the quarter ended June,30, 2008. Revenue for the ... million in the second quarter of 2007. The decrease ... year period was primarily due to,customer losses experienced during ...
... variation , , FRIDAY, Aug. 8 (HealthDay News) -- A British ... intake and high blood pressure. , The study, which included ... genetic factor that might make people more or less vulnerable ... variants of a gene for angiotensinogen, a molecule that can ...
Cached Medicine News:Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 2Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 3Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 4Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 5Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 2Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 3Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 4Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Infectious Disease and HealthShares(TM) Composite Indexes 2Health News:Breast-Feeding: The Stress Buster That Lasts for Years 2Health News:Breast-Feeding: The Stress Buster That Lasts for Years 3Health News:MedQuist Reports Second Quarter 2008 Results 2Health News:MedQuist Reports Second Quarter 2008 Results 3Health News:MedQuist Reports Second Quarter 2008 Results 4Health News:MedQuist Reports Second Quarter 2008 Results 5Health News:MedQuist Reports Second Quarter 2008 Results 6Health News:MedQuist Reports Second Quarter 2008 Results 7Health News:MedQuist Reports Second Quarter 2008 Results 8Health News:MedQuist Reports Second Quarter 2008 Results 9Health News:Too Much Salt Boosts Blood Pressure 2
(Date:8/28/2014)... , August 28, 2014 ... Market Research "Radiofrequency Identification (RFID) Market (Tags, Readers, Middleware, ... Growth, Trends and Forecast, 2014 - 2020" the global ... billion in 2013 and is expected to grow at ... reach an estimated value of USD 5.3 billion in ...
(Date:8/28/2014)... 28, 2014   Venaxis, Inc.  (Nasdaq:  APPY), an ... FDA clearance for and commercializing its CE Marked ... in identifying children, adolescent, and young adult patients in ... appendicitis, today announced it will present at three upcoming ... Annual Global Investment Conference being held in ...
(Date:8/28/2014)... 2014 Telik, Inc. (OTCQB: TELK), a ... with MabVax Therapeutics, Inc. on July 8, 2014, ... to the development of its lead antibody program ... the Company,s internally developed antibody discovery platform.  These ... antibody based therapeutic and diagnostic products based on ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
... traits contribute to risk, of skin cancer; findings will ... May 18 In two papers published,today, deCODE scientists ... the company,s recent findings in the genetics of pigmentation,traits ... of these,common variants also confer risk of two types ...
... Annual Meeting Will Further Demonstrate, the Strength ... CAMBRIDGE, Mass., May 16 Millennium Pharmaceuticals,The Takeda Oncology ... are scheduled to be featured at the 2008 American ... May 30 -,June 3, 2008. The data will highlight ...
Cached Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 2New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 5New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 6New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 7New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 8
... Ad-Techs Foramen Ovale Electrodes provide you ... These electrodes offer the same proven design ... that they are placed using an introducing ... a smaller electrode body diameter, 3 to ...
... The Small Joint Ball Electrode is ... small joint applications. With its 2 ... controlled capsuloligamentous or tendinous tissue coagulation ... used in conjunction with the OPES ...
... designed to replace the carpal scaphoid bone. The ... which fits under a shelf formed in the ... hole on the proximal hole for suture fixation. ... early postoperative period until a firm capsuloligamentous system ...
... Kompressor is a two-piece Titanium (Ti-6Al-4V) ... Mini) and a variety of lengths. The ... screw and sterile packaged. A single instrument ... or removal of both Standard and Mini ...
Medicine Products: